In Summary
Novo Nordisk is in week 5 of an open long with signal strength at 66 out of 100, ranked 92nd among the 170 longs running for US stocks in our ranking. The stop has been moved to breakeven: risk is zeroed out. 1 week to the first active management window.
Open BUY
·5th week from start
·US stocks
·T1
IQS Phase
50
ordinary
Signal Strength
66
medium
Sizing
STANDARD
Ranking
#92 / 170
US stocks in progress
restricted Platinum content